The healthcare and life sciences industries are changing at a remarkable pace. Advances in biotechnology, evolving treatment paradigms, increasing regulatory complexity, shifting patient expectations, and intense competition are reshaping how pharmaceutical and healthcare companies make strategic decisions.For executives and investors, having access to market information is no longer enough. The..